Comparison of high intensity focused ultrasound and radioiodine for treating toxic thyroid nodules.

Abstract:

PURPOSE:We compared the effectiveness of high intensity focused ultrasound (HIFU) and radioiodine (RAI) to treat patients carrying toxic thyroid nodule (TTN). Normalization of serum thyrotropin (TSH) 1 year after treatment was the primary end-point; concurrent changes in nodules' volume and scintigraphic pattern were also evaluated as secondary end-points. MATERIALS AND METHODS:Among patients ≥18 years old with TTN observed at our centre between January 1st, 2016 and December 31th, 2016 we prospectively enrolled 17 and 15 age and sex-matched patients treated with RAI and HIFU, respectively. Biochemical thyroid tests and nodules' volume were assessed before and 3, 6 and 12 months after treatments. A thyroid scintigraphy was performed before and 1 year after treatment, respectively. RESULTS:The final series included 17 patients treated with RAI and 15 patients treated with HIFU, respectively. Neither demographic nor clinical differences were found at baseline. One year after treatment 14 of 17 RAI-treated and 4 of 15 HIFU-treated patients fulfilled criteria for response to treatment (P = .0008). Indeed, the median TSH value was 1.5 IU/mL and 0.2 IU/mL in HIFU and RAI groups, respectively (P < .0001). Finally, despite a similar decrease in nodules' volume in both groups, a scintigraphic response was achieved in 16 of 17 (94%) RAI-treated compared to 8 of 15 (53%) HIFU-treated patients (P = .024), respectively. CONCLUSIONS:In our series, RAI clearly outperforms HIFU in treating patients carrying TTN and remains the first-line noninvasive treatment in such cases.

journal_name

Clin Endocrinol (Oxf)

journal_title

Clinical endocrinology

authors

Giovanella L,Piccardo A,Pezzoli C,Bini F,Ricci R,Ruberto T,Trimboli P

doi

10.1111/cen.13738

subject

Has Abstract

pub_date

2018-08-01 00:00:00

pages

219-225

issue

2

eissn

0300-0664

issn

1365-2265

journal_volume

89

pub_type

杂志文章
  • The effect of single-dose orlistat on postprandial serum glucose, insulin and glucagon-like peptide-1 levels in nondiabetic obese patients.

    abstract:OBJECTIVE:Glucagon-like peptide-1 is an insulin secretion-stimulating gut hormone that is produced in response to food intake. Orlistat (Xenical, F. Hoffman-La Roche, Basel, Switzerland), which decreases fat absorption and increases intestinal fat content, may therefore affect the secretion of glucagon-like peptide-1. ...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章,随机对照试验

    doi:10.1111/j.1365-2265.2007.02888.x

    authors: Sahin M,Tanaci N,Yucel M,Tutuncu NB,Guvener N

    更新日期:2007-09-01 00:00:00

  • Effects of exercise-induced weight loss on acylated and unacylated ghrelin in overweight children.

    abstract:OBJECTIVE:Controversial data on ghrelin concentration during exercise in human subjects have been published. We tested the hypothesis that exercise could affect acylated ghrelin (AG) and unacylated ghrelin (UAG), which could partly explain the previously reported inconsistent findings on the association of exercise wit...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章,随机对照试验

    doi:10.1111/j.1365-2265.2007.03058.x

    authors: Kim HJ,Lee S,Kim TW,Kim HH,Jeon TY,Yoon YS,Oh SW,Kwak H,Lee JG

    更新日期:2008-03-01 00:00:00

  • Chromogranin A as serum marker of pituitary adenomas.

    abstract:OBJECTIVE:The diagnostic impact of chromogranin A (CgA) measurement has been studied in various neuroendocrine tumours (NET) such as pheochromocytomas, gastrinomas and neuroblastomas. Clinically nonfunctioning pituitary adenomas (NFPA) are generally diagnosed on tumoural symptoms or hypopituitarism and, except for gona...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1046/j.1365-2265.2003.01902.x

    authors: Gussi IL,Young J,Baudin E,Bidart JM,Chanson P

    更新日期:2003-11-01 00:00:00

  • Autonomous cortisol secretion in adrenal incidentalomas and increased visceral fat accumulation during follow-up.

    abstract:OBJECTIVE:Autonomous cortisol secretion of adrenal incidentalomas (AIs) is associated with poor cardiovascular outcome. Because centripetal obesity is a cardiovascular risk factor, we aimed to investigate whether autonomous cortisol secretion is associated with increased visceral fat accumulation. DESIGN:Retrospective...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/cen.13408

    authors: Yener S,Baris M,Peker A,Demir O,Ozgen B,Secil M

    更新日期:2017-11-01 00:00:00

  • The levels and subcellular distribution of hormones and marker enzymes in pituitaries from control subjects and patients with prolactinomas, acromegaly or functionless pituitary tumours.

    abstract::Pituitary homogenates were prepared from patients undergoing pituitary ablation for breast or prostatic carcinoma (controls) and from patients with either PRL- and GH-secreting pituitary adenomas or from patients with 'functionless' pituitary tumours. The principal subcellular organelles, plasma membrane, lysosomes, m...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.1984.tb01389.x

    authors: De Marco L,Mashiter K,Peters TJ

    更新日期:1984-11-01 00:00:00

  • The cellular and molecular basis of the ectopic ACTH syndrome.

    abstract::In recent years the techniques of molecular and cellular biology have made it possible to begin to dissect the origins and behaviour of the ACTH-secreting tumour cell. It is becoming apparent that these tumours represent undifferentiated neuroendocrine cells, and it may be that their peptide-secreting properties may h...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章,评审

    doi:10.1111/j.1365-2265.1993.tb01765.x

    authors: White A,Clark AJ

    更新日期:1993-08-01 00:00:00

  • Prevalence of hypocalcaemia and its associated features in 22q11·2 deletion syndrome.

    abstract:BACKGROUND:22q11.2 deletion syndrome (22q11.2DS) is a relatively common yet under-recognized genetic syndrome that may present with endocrine features. We aimed to address the factors that contribute to the high prevalence of hypocalcaemia. METHODS:We investigated hypocalcaemia in a well-characterized sample of 138 ad...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/cen.12466

    authors: Cheung EN,George SR,Costain GA,Andrade DM,Chow EW,Silversides CK,Bassett AS

    更新日期:2014-08-01 00:00:00

  • Growth hormone treatment affects brain neurotransmitters and thyroxine [see comment].

    abstract:OBJECTIVE:Binding sites specific for growth hormone have been identified in the brain, but the action of GH on the central nervous system is still poorly understood. DESIGN:In a double-blind, placebo-controlled 21-month trial with a cross-over design, with each treatment period lasting for 9 months, we investigated th...

    journal_title:Clinical endocrinology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1046/j.1365-2265.1996.617439.x

    authors: Burman P,Hetta J,Wide L,Månsson JE,Ekman R,Karlsson FA

    更新日期:1996-03-01 00:00:00

  • Characterization of two novel mutations in the glucocorticoid receptor gene in patients with primary cortisol resistance.

    abstract:OBJECTIVE:Primary glucocorticoid resistance is characterized by decreased sensitivity to cortisol signalling. We have performed genetic analysis of the glucocorticoid receptor (GR) gene in 12 unrelated patients with primary cortisol resistance as defined by a pathological dexamethasone suppression test. METHODS:Exon s...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1046/j.1365-2265.2001.01323.x

    authors: Ruiz M,Lind U,Gåfvels M,Eggertsen G,Carlstedt-Duke J,Nilsson L,Holtmann M,Stierna P,Wikström AC,Werner S

    更新日期:2001-09-01 00:00:00

  • Acid glycosaminoglycans in myxoedema.

    abstract::Acid glycosaminoglycans were measured in the tissues of a virtually untreated 83-year-old woman with myxoedema. Intercellular oedema was demonstrated histologically in the tongue, myocardium, striated muscles, and in the skin. Tissue oedema was absent in two female control patients. All tissues from the patient with m...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.1982.tb03166.x

    authors: Parving HH,Helin G,Garbarsch C,Johansen AA,Jensen BA,Helin P,Lund P,Lyngsøe J

    更新日期:1982-02-01 00:00:00

  • A concerted decline in insulin secretion and action occurs across the spectrum of fasting and postchallenge glucose concentrations.

    abstract:AIMS/HYPOTHESIS:Individuals with impaired fasting glucose (IFG) are at increased risk of developing diabetes over the subsequent decade. However, there is uncertainty as to the mechanisms contributing to the development of diabetes. We sought to quantitate insulin secretion and action across the prediabetic range of fa...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.2011.04159.x

    authors: Sathananthan A,Dalla Man C,Zinsmeister AR,Camilleri M,Rodeheffer RJ,Toffolo G,Cobelli C,Rizza RA,Vella A

    更新日期:2012-02-01 00:00:00

  • The glutamine 27 glutamic acid polymorphism of the beta2-adrenoceptor gene is associated with abdominal obesity and greater risk of impaired glucose tolerance in men but not in women: a population-based study in Spain.

    abstract:OBJECTIVE:Given the important role of the beta2-adrenoceptor (beta2-AR) in lipid mobilization and the lack of studies in Southern European countries, the aim of this study was to investigate the role of the glutamine 27 glutamic acid (Gln27Glu) beta2-AR polymorphism in the susceptibility to obesity and its metabolic co...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1046/j.1365-2265.2003.01871.x

    authors: González Sánchez JL,Proenza AM,Martínez Larrad MT,Ramis JM,Fernández Pérez C,Palou A,Serrano Ríos M

    更新日期:2003-10-01 00:00:00

  • Cushing's disease in older patients: Presentation and outcome.

    abstract:BACKGROUND:To define the symptoms, signs and treatment outcomes in a population of older patients with Cushing's disease (CD). METHODS:We analysed the clinical presentation and treatment outcomes in 45 CD patients older than 60 years, in comparison with 90 CD patients younger than 60, and a control group of 45 older p...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/cen.13799

    authors: Qiao N,Swearingen B,Tritos NA

    更新日期:2018-10-01 00:00:00

  • Diagnostic accuracy of [¹⁸F]-fluoro-L-dihydroxyphenylalanine positron emission tomography scan for persistent congenital hyperinsulinism in Japan.

    abstract:OBJECTIVE:We aimed to elucidate the accuracy and limitations of [(18)F]-fluoro-L-dihydroxyphenylalanine ([(18) F]DOPA) positron emission tomography (PET) for Japanese patients with congenital hyperinsulinism. Although [(18)F]DOPA PET is reported to be useful for precisely localizing the focal form of congenital hyperin...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.2011.04072.x

    authors: Masue M,Nishibori H,Fukuyama S,Yoshizawa A,Okamoto S,Doi R,Uemoto S,Tokumi T,Kasai T,Yorifuji T

    更新日期:2011-09-01 00:00:00

  • Supplementation of vitamin D in pregnancy and its correlation with feto-maternal outcome.

    abstract:CONTEXT:Vitamin D deficiency is widely prevalent throughout the world. Pregnant women, neonates and infants form most vulnerable groups for vitamin D deficiency. OBJECTIVE:(1) To find prevalence of vitamin D deficiency in pregnant women. (2) To evaluate the effect of supplementation with cholecalciferol in improving v...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章,随机对照试验

    doi:10.1111/cen.12751

    authors: Sablok A,Batra A,Thariani K,Batra A,Bharti R,Aggarwal AR,Kabi BC,Chellani H

    更新日期:2015-10-01 00:00:00

  • Heterogeneous distribution of thyrotrophin receptor messenger ribonucleic acid (TSH-R mRNA) in papillary thyroid carcinomas detected by in situ hybridization.

    abstract:OBJECTIVE:TSH suppression therapy has been reported to be effective in some cases of papillary carcinoma of the thyroid. However, there has been little information regarding the status of expression of TSH-R mRNA in papillary carcinomas. Therefore, we examined the expression of TSH receptor (TSH-R) mRNA in thyroid tumo...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:

    authors: Tanaka K,Inoue H,Miki H,Komaki K,Monden Y

    更新日期:1996-03-01 00:00:00

  • Is the management of thyroid nodules and differentiated thyroid cancer in accordance with recent consensus guidelines? - Results of a national survey.

    abstract:OBJECTIVE:To assess approaches to patients with a potentially malignant thyroid nodule and patients with differentiated thyroid carcinoma and compare them with the European Consensus and Guidelines by the American Thyroid Association. DESIGN:A survey of the 388 active members of the Belgian Thyroid Club. METHODS:A qu...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.2007.03092.x

    authors: Van den Bruel A,Moreno-Reyes R,Bex M,Daumerie C,Glinoer D

    更新日期:2008-04-01 00:00:00

  • Suppression of parathyroid hormone inhibitory activity of plasma in pseudohypoparathyroidism type I by i.v. calcium.

    abstract::The biological response, as measured in the cytochemical bioassay, to the high circulating levels of immunoreactive parathyroid hormone (iPTH) in patients with pseudohypoparathyroidism type I (PSPI) is affected by the presence of an endogenous inhibitor. This is evidenced by the reduced recovery of the biological acti...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.1986.tb03284.x

    authors: Loveridge N,Fischer JA,Devogelaer JP,Nagant de Deuxchaisnes C

    更新日期:1986-05-01 00:00:00

  • Visceral adipose tissue accumulation and cardiovascular disease risk profile in postmenopausal women with impaired glucose tolerance or type 2 diabetes.

    abstract:OBJECTIVE:Women with impaired glucose tolerance (IGT) and type 2 diabetes (T2D) are more at risk of cardiovascular disease. The aim of this study was to test the hypothesis that increased visceral adipose tissue (VAT) could explain to a large extent alterations in the cardiovascular disease risk profile of postmenopaus...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.2010.03933.x

    authors: Lemieux S,Bédard A,Piché MÈ,Weisnagel SJ,Corneau L,Bergeron J

    更新日期:2011-03-01 00:00:00

  • Unacylated ghrelin is associated with changes in insulin sensitivity and lipid profile during an exercise intervention.

    abstract:OBJECTIVE:Ghrelin has been implicated in energy homeostasis, body weight regulation and glucose metabolism. Level of unacylated ghrelin (UAG), but not acylated ghrelin (AG), has been suggested to increase during long-term exercise. However, the association of the level of UAG with exercise-induced changes of insulin se...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.2011.04135.x

    authors: Cederberg H,Koivisto VM,Jokelainen J,Surcel HM,Keinänen-Kiukaanniemi S,Rajala U

    更新日期:2012-01-01 00:00:00

  • Effect of thyroxine on the inactivation of thyrotrophin-releasing hormone by rat and human plasma.

    abstract::The inactivation of synthetic [3H]thyrotrophin-releasing hormone (TRH) by plasma was studied in rats treated with propylthiouracil (PTU) alone or with PTU and thyroxine. 48 h after the onset of treatment with thyroxine, the capacity of rat plasma to inactivate [3H]TRH was significantly increased. The percentage of dea...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.1976.tb01961.x

    authors: Dupont A,Labrie F,Levasseur L,Dussault JH,Schally AV

    更新日期:1976-07-01 00:00:00

  • Integration of a postoperative calcitonin measurement into an anatomical staging system improves initial risk stratification in medullary thyroid cancer.

    abstract:OBJECTIVE:Staging systems applied to medullary thyroid cancer (MTC) rely on initial clinical and pathological features and do not consider the response to treatment. To determine whether MTC staging can be improved by incorporating the first postoperative calcitonin measurement. PATIENTS AND MEASUREMENTS:Eighty-five p...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/cen.12657

    authors: Yang JH,Lindsey SC,Camacho CP,Valente FO,Germano-Neto F,Machado AL,Mamone MC,Brodskyn F,Biscolla RP,Tuttle RM,Dias-da-Silva MR,Maciel RM

    更新日期:2015-12-01 00:00:00

  • Insulin secretion, insulin sensitivity and glucose-mediated glucose disposal in thyrotoxicosis: a minimal model analysis.

    abstract::In order to evaluate simultaneously in thyrotoxic subjects the relative contributions of insulin secretion, insulin-sensitivity (SI) and glucose-mediated (SG) glucose disposal to overall glucose tolerance, seven non-obese patients with thyrotoxicosis were studied by the minimal model analysis of the frequently sampled...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:

    authors: Pestell R,Alford F,Ramos R,Sawyer S,Best J,Ward G

    更新日期:1990-10-01 00:00:00

  • Chemerin and prediction of Diabetes mellitus type 2.

    abstract:OBJECTIVE:Insulin resistance and subclinical inflammation are characteristics in the development of type 2 diabetes mellitus (T2DM). The adipokine chemerin has been associated with both factors. The aim of this study was to analyse whether chemerin predicts T2DM. DESIGN:Blood samples of 440 participants of the Metabol...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/cen.12707

    authors: Bobbert T,Schwarz F,Fischer-Rosinsky A,Maurer L,Möhlig M,Pfeiffer AF,Mai K,Spranger J

    更新日期:2015-06-01 00:00:00

  • Peroxisome proliferator-activated receptor gamma agonism modifies the effects of growth hormone on lipolysis and insulin sensitivity.

    abstract:CONTEXT:Peroxisome proliferator-activated receptor gamma (PPAR-gamma) agonists such as thiazolidinediones (TZDs) improve insulin sensitivity in type 2 diabetes mellitus (T2DM) through effects on fat metabolism whereas GH stimulates lipolysis and induces insulin resistance. OBJECTIVE:To evaluate the impact of TZDs on f...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章,随机对照试验

    doi:10.1111/j.1365-2265.2008.03231.x

    authors: Krag MB,Nielsen S,Guo Z,Pedersen SB,Schmitz O,Christiansen JS,Jørgensen JO

    更新日期:2008-09-01 00:00:00

  • Correlation between plasma calcium, parathyroid hormone (PTH) and the metabolic syndrome (MetS) in a community-based cohort of men and women.

    abstract:CONTEXT:In recent years, an association has been noted between several abnormalities that characterize the metabolic syndrome (MetS) and primary hyperparathyroidism (pHPT). These abnormalities include dyslipidaemia, obesity, insulin resistance and hypertension. The correlations between plasma calcium, parathyroid hormo...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.2009.03558.x

    authors: Ahlström T,Hagström E,Larsson A,Rudberg C,Lind L,Hellman P

    更新日期:2009-11-01 00:00:00

  • Isolated growth hormone (GH) deficiency due to compound heterozygosity for two new mutations in the GH-releasing hormone receptor gene.

    abstract:OBJECTIVE:Mutations in the GH releasing hormone receptor (GHRH-R) have recently been shown to cause autosomal recessive isolated GH deficiency (IGHD). Patients who are homozygous for GHRH-R mutations have a subnormal GH response to pharmacological agents that stimulate GH secretion and an appropriate response to exogen...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1046/j.1365-2265.2001.01273.x

    authors: Salvatori R,Fan X,Phillips JA 3rd,Prince M,Levine MA

    更新日期:2001-05-01 00:00:00

  • Changes in pituitary gonadotropins during the amenorrhoea-galactorrhoea syndrome due to sulpiride.

    abstract::Sulpiride, a dopamine receptor blocker which raises prolactin, was given to six women with idiopathic amenorrhoea for 10 days and to eleven women with regular cycles for 3 to 6 months. The latter group developed galactorrhoea and amenorrhoea during treatment. Basal LH AND FSH concentrations showed no significant chang...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.1978.tb01507.x

    authors: Buvat J,Thomas K,Racadot A,Blacker C,Buvat-Herbaut M,Ferin F,Linquette M

    更新日期:1978-12-01 00:00:00

  • Recovery of adrenal function after treatment of adrenocortical carcinoma with o,p'-DDD.

    abstract::The adrenolytic agent, 2,2-bis[2-chlorophenyl-4-chlorophenyl] 1,1 dichloroethane (o,p'-DDD), was used over a 20-month period following surgery in a 2 3/12-year-old girl for treatment of adrenocortical carcinoma. The child remained free of disease and was maintained on glucocorticoid and mineralo-corticoid supplements ...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.1984.tb03434.x

    authors: Greig F,Oberfield SE,Levine LS,Ghavimi F,Pang S,New MI

    更新日期:1984-04-01 00:00:00

  • Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas.

    abstract:OBJECTIVE:Parathyroid carcinoma remains difficult to diagnose. Recently, it has been shown that mutations in the HRPT2 gene (encoding parafibromin) are associated with the development of parathyroid carcinoma. Although MEN1 is not typically thought to be involved in carcinoma formation, parathyroid carcinoma may be an ...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.2007.02894.x

    authors: Haven CJ,van Puijenbroek M,Tan MH,Teh BT,Fleuren GJ,van Wezel T,Morreau H

    更新日期:2007-09-01 00:00:00